Breaking News

WuXi Passes EMEA Inspection

WuXi PharmaTech received a certificate of GMP compliance from the Medical Products Agency (MPA) of Sweden, on behalf of the European Medicines Agency (EMEA), for its cGMP drug product manufacturing and analytical testing facilities in Shanghai.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

WuXi PharmaTech received a certificate of GMP compliance from the Medical Products Agency (MPA) of Sweden, on behalf of the European Medicines Agency (EMEA), for its cGMP drug product manufacturing and analytical testing facilities in Shanghai. The Shanghai facility produces solid oral dosage forms for use in clinical trials; the analytical testing facility develops and validates methods of analyzing APIs and formulated drug products for properties such as potency, purity and solubility. Addi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters